|
⚲
|
| Keyboard |
| Foletta Mark G
✚
|
|
|---|---|
| CIK # | 0001236389 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001236389] | |
| 4 | [0001236389] | |
| 5 | [0001236389] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Enanta Pharmaceuticals Inc ENTA
Stock Option (right to buy) · derivative
|
2026-03-11 | Grant | 20,000 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2025-08-15 | Sell | 2,555 | $81.02 | 207,006 |
|
Dexcom Inc DXCM
Common Stock
|
2025-08-15 | Sell | 195 | $81.54 | 15,900 |
|
Dexcom Inc DXCM
Common Stock
|
2025-07-15 | Sell | 8 | $86.03 | 688 |
|
Dexcom Inc DXCM
Common Stock
|
2025-07-15 | Sell | 2,742 | $85.17 | 233,536 |
|
Dexcom Inc DXCM
Common Stock
|
2025-06-16 | Sell | 2,750 | $83.13 | 228,608 |
|
Dexcom Inc DXCM
Common Stock
|
2025-05-08 | Gift | 2,973 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2025-05-08 | Grant | 5,731 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2025-05-08 | Gift | 2,973 | $0.00 | |
|
AMN Healthcare Services Inc AMN
Restricted Stock Units · derivative
|
2025-05-02 | Grant | 8,325 | $0.00 | |
|
AMN Healthcare Services Inc AMN
Common Stock
|
2025-04-19 | Option exercise | 3,019 | $0.00 | |
|
AMN Healthcare Services Inc AMN
Restricted Stock Units · derivative
|
2025-04-19 | Option exercise | 3,019 | $0.00 | |
|
Enanta Pharmaceuticals Inc ENTA
Stock Option (right to buy) · derivative
|
2025-03-13 | Grant | 15,700 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2024-06-18 | Sell | 3,007 | $116.75 | 351,067 |
|
Dexcom Inc DXCM
Common Stock
|
2024-06-18 | Sell | 299 | $117.25 | 35,058 |
|
Dexcom Inc DXCM
Common Stock
|
2024-06-17 | Sell | 475 | $117.77 | 55,941 |
|
Dexcom Inc DXCM
Common Stock
|
2024-06-17 | Sell | 2,212 | $117.16 | 259,158 |
|
Dexcom Inc DXCM
Common Stock
|
2024-06-17 | Sell | 7 | $115.18 | 806 |
|
Dexcom Inc DXCM
Common Stock
|
2024-05-22 | Grant | 2,973 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2024-05-18 | Gift | 3,306 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||